Adaptive Biotechnologies
Matthew Keefe, PhD, is a seasoned scientist with extensive experience in product development and regulatory compliance in biotechnology. Currently serving as Scientist II in Product Development at Adaptive Biotechnologies Corp., Matthew Keefe conducts verification and validation for regulated NGS-based immunosequencing products. Previously, at NanoString Technologies, Matthew led collaborative projects and managed R&D teams focused on high plex in situ gene expression profiling. A postdoctoral fellow at the University of Utah, Matthew developed a zebrafish model to study vanishing white matter disease. Early career experience includes a research associate role at Boston Children's Hospital and tutoring in chemistry at Plymouth State University. Matthew holds a PhD in Human Genetics from the University of Utah and a degree in Biology from Plymouth State University.
Adaptive Biotechnologies
17 followers
Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems. Adaptive’s proprietary immune profiling platform reveals and translates insights from our adaptive immune systems with unprecedented scale and precision.